Top 5 Drug Classes Advertising in Professional Health Journals (Pages) through April 2013
Advertisers in professional health journals purchased 29,337 total pages year-to-date, according to Kantar Media. Cancer Therapy Products came in as the top drug class with more than 1,900 pages and appeared as the highest ranked class when looking at the list by dollars. Steroids, Inhaled Bronch and Irritant Stimulant Laxatives switched spots when compared with last month, the former making up 545 ad pages and more than $4 million dollars.
The top product classes by pages are as follows:
Top 5 Print Ad Drug Classes (Pages): Jan. – April 2013
#1 Cancer Therapy Products – 2,759 pages (+10%)
#2 Anticoagulants Oral – 1,348 pages (+3%)
#3 Irritant Stimulant Laxatives– 545 pages (N/A)
#4 Steroids, Inhaled Bronch – 526 pages (N/A)
#5 Biological Response Modifier – 509 pages (+5%)
The percentage changes compare January – April 2013 to that same time period in 2012. For more information on these ad insights or other data, let one of us know.
Kantar Media sets the standard for accurate, comprehensive competitive advertising intelligence in the professional healthcare arena. Check back next month for updated data on the top products, classes, companies and category movers year-to-date.
Comments